Powered by

Clinical Trial Results, Milestone Payments, New Board Members, and Executive Appointments - Analyst Notes on Cubist, Clovis, Ligand, Bio-Techne and Repligen

Jun 16, 2014 - PR Newswire
Board and Executive Moves-Investments

Today, Analysts Review released its analysts' notes regarding Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Clovis Oncology, Inc. (NASDAQ: CLVS), Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), Techne Corp. (NASDAQ: TECH) and Repligen Corporation (NASDAQ: REGN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at:

http://www.analystsreview.com/3298-100free.--Cubist Pharmaceuticals Inc. Analyst NotesOn Jun...